Transdermal Skin Patches Market Size, Share and Analysis Forecast 2023-2028
Transdermal Skin Patches Market Size, Share and Analysis Forecast 2023-2028
Presently, the growing geriatric population and increasing demand for non-invasive treatments represent one of the key factors positively influencing the market.

IMARC Group, a leading market research company, has recently releases report titled “Transdermal Skin Patches Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global transdermal skin patches market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How Big is the Transdermal Skin Patches Market?

The global transdermal skin patches market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.4% during 2023-2028.

Transdermal skin patches refer to medical devices designed to deliver medication through the skin and into the bloodstream. They are made of a thin, flexible material that adheres to the skin and contains a specific amount of medication. They aid in slowly releasing the medicine through the skin into the bloodstream and provide a consistent dose of the drug.  At present, they are used to deliver a variety of medications for pain relief, hormonal therapy, nicotine replacement therapy, and overactive bladder.

Request Free Sample Copy of This Report: https://www.imarcgroup.com/transdermal-skin-patches-market/requestsample

What are the growth prospects and trends in the transdermal skin patches industry?

Presently, the growing geriatric population and increasing demand for non-invasive treatments represent one of the key factors positively influencing the market. In addition, the increasing prevalence of chronic diseases, such as diabetes, hypertension, and cardiovascular disorders, are catalyzing the demand for transdermal skin patches for managing these conditions as they provide a consistent and reliable dose of medication over an extended period.

Moreover, the rising popularity of transdermal nicotine patches among people who are trying to quit smoking is creating a favorable market outlook. Besides this, key market players are introducing biodegradable microneedle patches for transdermal delivery, which is contributing to the market growth.

Furthermore, governments of various countries are taking favorable initiatives to improve drug delivery and reduce healthcare costs, which is stimulating the market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Matrix
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by Application:

  • Pain Relief
  • Smoking Reduction and Cessation Aid
  • Overactive Bladder
  • Hormonal Therapy
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including: 

3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group?, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations